Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: Role in epithelial-mesenchymal transition

Cancer Research

Volumn 66, Issue 2, 2006, Pages 889-897

  Yoshida, Hiroyuki ^a   Broaddus, Russell ^a   Cheng, Wenjun ^a   Xie, Susu ^a   Naora, Honami ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA1 INTEGRIN; CADHERIN; GENOMIC DNA; HOMEODOMAIN PROTEIN; KI 67 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION REGULATION; HOMEOBOX; HOXA10 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYME; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CARCINOMA; CELL ADHESION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MESODERM; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED;

EID: 31544476839     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2828     Document Type: Article

References (47)

1. Thiery JP. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002;2:442-54.
2. De Craene B, van Roy F, Berx G. Unraveling signaling cascades for the Snail family of transcription factors. Cell Signal 2005;17:535-47.
3. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992;68:283-302.
4. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002; 2:777-85.
5. Samuel S, Naora H. Homeobox gene expression in cancer: Insights from developmental regulation and deregulation. Eur J Cancer 2005;41:2428-37.
6. Dressier GR, Douglass EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A 1992;89:1179-83.
7. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 2003; 22:7989-97.
8. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, et al. Roles for NkxS.1 in prostate development and cancer. Genes Dev 1999;13:966-77.
9. He WW, Sciavolino PJ, Wing J, et al. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 1997;43:69-77.
10. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, et al. NkxS.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 2002;62:2999-3004.
11. Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. A review. J Reprod Med 2002;47:173-90.
12. Alektiar KM, McKee A, Lin O, et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer? Int J Radiat Oncol Biol Phys 2002; 54:79-85.
13. Dunton CJ, Balsara G, McFarland M, Hernandez E. Uterine papillary serous carcinoma: a review. Obstet Gynecol Surv 1991;46:97-102.
14. Sarno JL, Kliman H, Taylor HS. HOXA10, Pbx2 and Meisl protein expression in the human endometrium: formation of multimeric complexes on HOXA10 target genes. J Clin Endocrinol Metab 2005;90:522-8.
15. Satokata I, Benson GV, Maas RL. Sexually dimorphic sterility phenotypes in Hoxa10-deficient mice. Nature 1995;374:460-3.
16. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 1996;122:2687-96.
17. Cheng W, Liu J, Yoshida H, Rosen D, Naora H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med 2005;11:531-7.
18. Boyd JA, Rinehart CAJ, Walton LA, Siegel GP, Kaufman DG. Ultrastructural characterization of two new human endometrial carcinoma cell lines and normal human endometrial epithelial cells cultured on extracellular matrix. In Vitro Cell Dev Biol 1990;26: 701-8.
19. Richardson GS, Dickersin GR, Atkins L, et al. KLE, a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol 1984;17:213-30.
20. Ramondetta L, Mills GB, Burke TW, Wolf JK. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res 2000;6:278-84.
21. Dai D, Kumar NS, Wolf DM, Leslie KK. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Am J Obstet Gynecol 2001;184: 790-7.
22. Dai D, Wolf DM, Litman ES, White MJ, Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 2002;62:881-6.
23. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
24. Batlle E, Sancho E, Franci C, et al. The transcriptional factor Snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat Cell Biol 2000;2:84-9.
25. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62:1613-8.
26. Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000;405:974-8.
27. Whitcomb, BP, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Goodfellow PJ. Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. Clin Cancer Res 2003;9: 2277-87.
28. Naora H, Montz FJ, Chai CY, Roden RB. Aberrant expression of homeobox gene HOXA7 is associated with mullerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc Natl Acad Sci U S A 2001;98: 15209-14.
29. Keller MS, Ezaki T, Guo RJ, Lynch JP. Cdx1 or Cdx2 expression activates E-cadherin-mediated cell-cell adhesion and compaction in human COLO 205 cells. Am J Physiol Gastrointest Liver Physiol 2004;287:G104-14.
30. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118:277-9.
31. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003;113:207-19.
32. Taylor HS, Arid A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 1998;101:1379-84.
33. Kumar NS, Richer J, Owen G, Litman E, Horwitz KB, Leslie KK. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Cancer Res 1998;58:1860-5.
34. Sakaguchi H, Fujimoto J, Hong B, Nakagawa Y, Tamaya, T. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol 2004;93:394-9.
35. Lim H, Ma L, Ma WG, Maas RL, Dey SK. Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol Endocrinol 1999;13:1005-17.
36. Lane DB, Rutherford TJ, Taylor HS. HOXA10 expression in endometrial adenocarcinoma. Tumor Biol 2004; 25:264-9.
37. Chu MC, Selam FB, Taylor HS. HOXA10 regulates p53 expression and Matrigel invasion in human breast cancer cells. Cancer Biol Ther 2004;3:568-72.
38. Taylor HS, Bagot C, Kardana A, Olive D, Arid A HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 1999;14: 1328-31.
39. Zeitvogel A, Baumann R, Starzinski-Powitz A. Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 2001;159:1839-52.
40. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000;85:2897-902.
41. Scotti S, Regidor PA, Schindler AE, Winterhager E. Reduced proliferation and cell adhesion in endometriosis. Mol Hum Reprod 2000;6:610-7.
42. Hsieh-Li HM, Witte DP, Weinstein M, et al. Hoxa11 structure, extensive antisense transcription, and function in male and female fertility. Development 1995;121: 1373-85.
43. Taylor HS, Igarashi P, Olive DL, Arici A. Sex steroids mediate HOXA11 expression in the human periimplantation endometrium. J Clin Endocrinol Metab 1999;84:1129-35.
44. Ee HC, Erler T, Bhathal PS, Young GP, James RJ. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 1995; 147:586-92.
45. Bonhomme C, Duluc I, Martin E, et al. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 2003;52:1465-71.
46. Kim MJ, Cardiff RD, Desai N, et al. Cooperatively of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 2002; 99:2884-9.
47. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypic to a molecular-based classification. Virchows Arch 2004;444: 213-23.